Eyepoint, Inc.
Records under this name other than the patents Eyepoint, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 55 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,413,242 | Formulations of TIE-2 Activators and Methods of Use Thereof held by Eyepoint Pharmaceuticals, Inc. Lapsed on the fee record Ended Aug 16, 2026 · High confidence | Lapsed on the fee record | Ended Aug 16, 2026 | High confidence |
| US 8,790,293 | Injector Apparatus with Fixed Plunger and Method of Use held by Eyepoint Pharmaceuticals, Inc. Lapsed on the fee record Ended Jul 29, 2026 · High confidence | Lapsed on the fee record | Ended Jul 29, 2026 | High confidence |
| US 8,329,916 | Human Protein Tyrosine Phosphatase Inhibitors and Method of Use held by Eyepoint Pharmaceuticals, Inc. Lapsed on the fee record Ended Dec 11, 2024 · Medium confidence | Lapsed on the fee record | Ended Dec 11, 2024 | Medium confidence |
| US 9,566,336 | In Situ Gelling Drug Delivery System Term ended Term ended Jun 25, 2024 · Medium confidence | Term ended | Term ended Jun 25, 2024 | Medium confidence |
| US 10,300,114 | Bioerodible Sustained Release Drug Delivery Systems held by Eyepoint Pharmaceuticals, Inc. Term ended Term ended Jun 25, 2024 · High confidence | Term ended | Term ended Jun 25, 2024 | High confidence |
| US 8,192,408 | Ocular Trocar Assembly held by Eyepoint Pharmaceuticals, Inc. Lapsed on the fee record Ended Jun 5, 2024 · High confidence | Lapsed on the fee record | Ended Jun 5, 2024 | High confidence |
| US 8,106,078 | Human Protein Tyrosine Phosphatase Inhibitors and Methods of Use held by Eyepoint Pharmaceuticals, Inc. Lapsed on the fee record Ended Jan 31, 2024 · High confidence | Lapsed on the fee record | Ended Jan 31, 2024 | High confidence |
| US 10,363,163 | Injector Apparatus held by Eyepoint Pharmaceuticals, Inc. Lapsed on the fee record Ended Jul 30, 2023 · High confidence | Lapsed on the fee record | Ended Jul 30, 2023 | High confidence |
| US 6,936,270 | Device and Method for Treating Conditions of a Joint Term ended Term ended Nov 2, 2021 · Medium confidence | Term ended | Term ended Nov 2, 2021 | Medium confidence |
| US 8,574,659 | Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof held by Eyepoint Pharmaceuticals, Inc. Term ended Ended no later than Jun 8, 2020 · Low confidence | Term ended | Ended no later than Jun 8, 2020 | Low confidence |